Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Inoue, Jun ^a,c   Misawa, Akiko ^a,c   Tanaka, Yukichi ^d   Ichinose, Shizuko ^a   Sugino, Yuriko ^a,e   Hosoi, Hajime ^e   Sugimoto, Tohru ^e,f   Imoto, Issei ^a,c   Inazawa, Johji ^a,b,c  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Global Center of Excellence (GCOE) Program   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f Medical Care Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 5; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; LAPTM5 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CATECHOLAMINE URINE LEVEL; CELL DEATH; CELL DEGENERATION; CELL INCLUSION; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE COURSE; DNA METHYLATION; DOWN REGULATION; GANGLIONEUROMA; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYSOSOME; MASS SCREENING; NEUROBLASTOMA; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SOLID TUMOR; TUMOR REGRESSION; UBIQUITINATION; UPREGULATION; CHILD; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; REMISSION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; CATECHOLAMINES; CELL LINE, TUMOR; CHILD; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYSOSOMES; MEMBRANE PROTEINS; NEUROBLASTOMA; REMISSION, SPONTANEOUS; UP-REGULATION;

EID: 70349640631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007099     Document Type: Article

References (47)

1. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
2. Schwab M, Westermann F, Hero B, Berthold F (2003) Neuroblastoma. biology and molecular and chromosomal pathology. Lancet Oncol 4: 472-480.
3. Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369: 2106-2120.
4. Pritchard J, Hickman JA (1994) Why does stage 4s neuroblastoma regress spontaneously? Lancet 344: 869-870.
5. Reynolds CP (2002) Ras and Seppuku in neuroblastoma. J Natl Cancer Inst 94: 319-321.
6. Hoehner JC, Gestblom C, Olsen L, Pahlman S (1997) Spatial association of apoptosis-related gene expression and cellular death in clinical neuroblastoma. Br J Cancer 75: 1185-1194.
7. Ikeda H, Hirato J, Akami M, Matsuyama S, Suzuki N, et al. (1995) Bcl-2 oncoprotein expression and apoptosis in neuroblastoma. J Pediatr Surg 30: 805-808.
8. Koizumi H, Wakisaka M, Nakada K, Takakuwa T, Fujioka T, et al. (1995) Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression. Virchows Arch 427: 167-173.
9. Oue T, Fukuzawa M, Kusafuka T, Kohmoto Y, Imura K, et al. (1996) In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma. J Pediatr Surg 31: 251-257.
10. Tonini GP, Mazzocco K, di Vinci A, Geido E, de Bernardi B, et al. (1997) Evidence of apoptosis in neuroblastoma at onset and relapse: An analysis of a large series of tumors. J Neurooncol 31: 209-215.
11. Koizumi H, Hamano S, Doi M, Tatsunami S, Nakada K, et al. (2006) Increased occurrence of caspase-dependent apoptosis in unfavorable neuroblastomas. Am J Surg Pathol 30: 249-257.
12. Kitanaka C, Kato K, Ijiri R, Sakurada K, Tomiyama A, et al. (2002) Increased Ras expression and caspase-independent neuroblastoma cell death: possible mechanism of spontaneous neuroblastoma regression. J Natl Cancer Inst 94: 358-368.
13. Kodet R (1998) Ultrastructural observations on neuroblastic tumors in childhood. a study of tumor cell differentiation and regression on 89 cases. Cesk Patol 34: 123-130.
14. Yamamoto K, Hanada R, Kikuchi A, Ichikawa M, Aihara T, et al. (1998) Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 16: 1265-1269.
15. Fritsch P, Kerbl R, Lackner H, Urban C (2004) "Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening. Pediatr Blood Cancer 43: 679-682.
16. Oue T, Inoue M, Yoneda A, Kubota A, Okuyama H, et al. (2005) Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study. J Pediatr Surg 40: 359-363.
17. Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, et al. (2008) Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol 26: 1504-1510.
18. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312.
19. Inazawa J, Inoue J, Imoto I (2004) Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci 95: 559-563.
20. Misawa A, Inoue J, Sugino Y, Hosoi H, Sugimoto T, et al. (2005) Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res 65: 10233-10242.
21. Sugino Y, Misawa A, Inoue J, Kitagawa M, Hosoi H, et al. (2007) Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene 26: 7401-7413.
22. Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, et al. (2007) Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 26: 6456-6468.
23. Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132: 27-42.
24. Mizushima N (2007) Autophagy: process and function. Genes Dev 21: 2861-2873.
25. Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, et al. (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614.
26. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, et al. (2007) p62/ SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282: 24131-24145.
27. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al. (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884.
28. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, et al. (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889.
29. Adra CN, Zhu S, Ko JL, Guillemot JC, Cuervo AM, et al. (1996) LAPTM5: a novel lysosomal-associated multispanning membrane protein preferentially expressed in hematopoietic cells. Genomics 35: 328-337.
30. Pak Y, Glowacka WK, Bruce MC, Pham N, Rotin D (2006) Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination. J Cell Biol 175: 631-645.
31. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, et al. (2003) Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197: 1323-1334.
32. Boya P, Kroemer G (2008) Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434-6451.
33. Kroemer G, Jää ttelä M (2005) Lysosomes and autophagy in cell death control. Nat Rev Cancer 5: 886-897.
34. Tardy C, Codogno P, Autefage H, Levade T, Andrieu-Abadie N (2006) Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle). Biochim Biophys Acta 1765: 101-125.
35. Yuan XM, Li W, Dalen H, Lotem J, Kama R, et al. (2002) Lysosomal destabilization in p53-induced apoptosis. Proc Natl Acad Sci U S A 99: 6286-6291.
36. Cortese R, Hartmann O, Berlin K, Eckhardt F (2008) Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer. Int J Biochem Cell Biol 40: 1494-1508.
37. Brodeur GM, Sekhon G, Goldstein MN (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256-2263.
38. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, et al. (2001) Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas. Med Pediatr Oncol 36: 42-44.
39. Fujita T, Igarashi J, Okawa ER, Gotoh T, Manne J, et al. (2008) CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas. J Natl Cancer Inst 100: 940-949.
40. Munirajan AK, Ando K, Mukai A, Takahashi M, Suenaga Y, et al. (2008) KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death. J Biol Chem 283: 24426-24434.
41. Caron H, van Sluis P, de Kraker J, Bökkerink J, Egeler M, et al. (1996) Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334: 225-230.
42. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, et al. (1995) Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 55: 4664-4669.
43. Ouchida R, Yamasaki S, Hikida M, Masuda K, Kawamura K, et al. (2008) A lysosomal protein negatively regulates surface T cell antigen receptor expression by promoting CD3zeta-chain degradation. Immunity 29: 33-43.
44. Karlsson K, Carlsson SR (1998) Sorting of lysosomal membrane glycoproteins lamp-1 and lamp-2 into vesicles distinct from mannose 6-phosphate receptor/gamma-adaptin vesicles at the trans-Golgi network. J Biol Chem 273: 18966-18973.
45. Fehrenbacher N, Bastholm L, Kirkegaard-Sørensen T, Rafn B, Bøttzauw T, et al. (2008) Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res 68: 6623-6633.
46. Brundin P, Li JY, Holton JL, Lindvall O, Revesz T (2008) Research in motion. the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci 9: 741-745.
47. Gonzalgo ML, Liang G (2007) Methylation-sensitive single-nucleotide primer extension (Ms-SNuPE) for quantitative measurement of DNA methylation. Nat Protoc 2: 1931-1936.